Bristol-Myers Squibb
BMY
BMY
2,142 hedge funds and large institutions have $95.3B invested in Bristol-Myers Squibb in 2020 Q1 according to their latest regulatory filings, with 144 funds opening new positions, 819 increasing their positions, 947 reducing their positions, and 178 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
2,142
Holders Change
-69
Holders Change %
-3.12%
% of All Funds
47.32%
Holding in Top 10
135
Holding in Top 10 Change
+29
Holding in Top 10 Change %
+27.36%
% of All Funds
2.98%
New
144
Increased
819
Reduced
947
Closed
178
Calls
$1.42B
Puts
$1.89B
Net Calls
-$469M
Net Calls Change
+$2.5B
Top Buyers
| 1 |
JPMorgan Chase & Co
New York
|
+$499M |
| 2 |
Renaissance Technologies
New York
|
+$322M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$225M |
| 4 |
LCM
Laurion Capital Management
New York
|
+$176M |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
+$170M |
Top Sellers
| 1 |
Dodge & Cox
San Francisco,
California
|
-$780M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$444M |
| 3 |
OAG
Orbis Allan Gray
Hamilton,
Bermuda
|
-$305M |
| 4 |
Two Sigma Advisers
New York
|
-$297M |
| 5 |
BG
Baupost Group
Boston,
Massachusetts
|
-$257M |
